NCT07216339 Gamification Effects on the 6-Minute Walk Test in Children
| NCT ID | NCT07216339 |
| Status | Recruiting |
| Phase | — |
| Sponsor | David Toupin |
| Condition | Neuromuscular Diseases in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-06-12 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-06-12 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to learn if adding a game to the 6-minute walk test for children with neuromuscular disorders will increase enjoyment and motivation to complete the test.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of, or active evaluation for, a neuromuscular disorder * Able to ambulate (with or without usual orthoses/assistive device) sufficiently to attempt a 6-minute walk. * Note: Acceptable if the patient needs to take breaks or sit during the test. Those unable to finish are counted as protocol deviations, not exclusions. * Medically stable on the test day (no acute illness or recent surgery that would contraindicate moderate exercise). * Child able to understand simple instructions in English and provide assent (if applicable based upon age and developmental level); parent/guardian able to provide consent in English. Exclusion Criteria: * Non-ambulatory or unsafe to attempt walking as judged by the treating physician. * Severe cognitive/behavioral impairment that precludes following instructions. * Acute cardiopulmonary, orthopedic, or other medical condition that makes walking unsafe on the test day. * Non-English-speaking family (materials are available only in English for this pilot). * Any child/parent who declines consent/assent or withdraws at any time.
Contact & Investigator
David N Toupin, MD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT07216339 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Neuromuscular Diseases in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07216339 currently recruiting?
Yes, NCT07216339 is actively recruiting participants. Contact the research team at d.n.toupin@uky.edu for enrollment information.
Where is the NCT07216339 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT07216339 clinical trial?
NCT07216339 is sponsored by David Toupin. The principal investigator is David N Toupin, MD at University of Kentucky. The trial plans to enroll 20 participants.